2,851
edits
Nicotinamide Mononucleotide (NMN): Difference between revisions
Nicotinamide Mononucleotide (NMN) (view source)
Revision as of 12:48, 15 September 2023
, 15 September 2023→Studies
| Line 116: | Line 116: | ||
* 35 years in average | * 35 years in average | ||
| | | | ||
* | * The combination of NMN supplementation and exercise further improves ventilatory threshold even among healthy young and middle-aged people. | ||
* The improvement of aerobic capacity is in a dosage-dependent, large dosage of NMN with exercise has better effects. | * The improvement of aerobic capacity is in a dosage-dependent, large dosage of NMN with exercise has better effects. | ||
* The improvement is muscle, not cardiac, related. | * The improvement is muscle, not cardiac, related. | ||